Azabicyclo-octane inhibitors of IAP

Details for Australian Patent Application No. 2005228950 (hide)

Owner Genentech, Inc.

Inventors Flygare, John; Fairbrother, Wayne; Keteltas, Stephen Franz; Cohen, Frederick; Tsui, Vickie Hsiao-Wei

Agent Griffith Hack

Pub. Number AU-B-2005228950

PCT Pub. Number WO2005/094818

Priority 60/555,755 23.03.04 US

Filing date 22 March 2005

Wipo publication date 13 October 2005

Acceptance publication date 2 February 2012

International Classifications

C07D 203/02 (2006.01) Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom

A61K 31/403 (2006.01) - condensed with carbocyclic rings, e.g. carbazole

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07K 5/06 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

Event Publications

31 August 2006 PCT application entered the National Phase

  PCT publication WO2005/094818 Priority application(s): WO2005/094818

2 February 2012 Application Accepted

  Published as AU-B-2005228950

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005228951-Agent eluting stent and catheter

2005228945-Factor IXa for the treatment of bleeding disorders